A team of Greenberg Traurig attorneys recently represented Intec Pharma Ltd. (NASDAQ and TASE: NTEC) on the closing of its offering of approximately 12.2 million of its ordinary shares, at…
Continue Reading Greenberg Traurig Advises Intec Pharma on $57.5M Offering